Molecular Partners AG
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Molecular Partners AG generated cash of -$59,005,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,167,000 last year. Net change in cash is therefore -$20,637,000.

Cash Flow

Molecular Partners AG (NASDAQ:MOLN): Cash Flow
2014 -11.33M -198.25K 101.18M
2015 26.49M -20.73M 229.19K
2016 -35.38M -11.25M 395K
2017 -40.02M 20.86M 799K
2018 -42.47M 9.61M 392K
2019 -1.18M -19.83M -227K
2020 -28.98M -21.74M 113.20M
2021 -90.95M -22.23M 50.58M
2022 118.56M -101.12M -1.57M
2023 -59.00M 44.63M -1.16M

MOLN Cash Flow Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash at beginning of period
87.94M71.81M133.72M75.71M98.95M131.31M149.73M195.37M188.38M96.12M
Operating activities
Net income
-61.98M117.85M-63.78M-62.76M-36.28M-37.03M-25.43M-18.61M-148.82K-2.28M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
2.42M2.38M2.56M2.88M2.46M924K1.14M1.08M909.38K809.53K
Stock-based compensation expense
5.20M5.08M4.08M2.93M2.43M03.59M2.85M3.75M2.26M
Deferred income tax benefit 5.20M5.08M4.08M2.93M2.43M03.59M2.85M3.75M2.26M
Changes in operating assets and liabilities:
Accounts receivable, net
-933K25.26M-23.37M-552K49.57M0-317K01.86M0
Inventories
0-19.92M21.71M-2.84M-49.57M00000
Accounts payable
-812K-5.33M1.65M3.39M-270K1.38M-118K-370K649.90K-69.89K
Cash generated by operating activities
-59.00M118.56M-90.95M-28.98M-1.18M-42.47M-40.02M-35.38M26.49M-11.33M
Investing activities
Purchases Of Investments
-277.82M-299.41M-88.87M-73.39M-75.99M-30.22M-19.43M-10.47M-20.02M0
Investments In Property Plant And Equipment
-575K-1.41M-1.30M-1.68M-1.86M-867K-500K-1.09M-1.38M-546.10K
Acquisitions Net
-45.21M0374K232K833K-411K-19K000
Cash generated by investing activities
44.63M-101.12M-22.23M-21.74M-19.83M9.61M20.86M-11.25M-20.73M-198.25K
Financing activities
Common Stock Issued
31K051.49M113.61M1.01M392K799K395K229.41K100.94M
Payments for dividends
0000000000
Repurchases of common stock
0-631K00000000
Repayments of term debt
-1.19M-1.18M-1.17M-1.25M-1.23M00000
Cash used in financing activities
-1.16M-1.57M50.58M113.20M-227K392K799K395K229.19K101.18M
Net Change In Cash
-20.63M16.13M-61.90M58.00M-23.24M-32.35M-18.41M-45.63M6.98M92.25M
Cash at end of period
67.30M87.94M71.81M133.72M75.71M98.95M131.31M149.73M195.36M188.38M
Data sourceData sourceData source